Purchase Order 75N91020P00168

<p>The National Cancer Institute awarded a purchase order to Polypeptide Laboratories San Diego, LLC for $14,000 on July 6, 2020. Work will be performed in San Diego, California. The order procures stability testing of reagents used in vaccine manufacturing to support two active clinical trials, with firm fixed price terms and an ultimate completion date of August 5, 2020.</p>

<p>The National Cancer Institute awarded a purchase order to Polypeptide Laboratories San Diego, LLC for $17,500 on December 4, 2020. The order covers mandatory retesting of GMP peptides used to manufacture clinical vaccines for prostate cancer patients, with performance in San Diego, California and completion by January 3, 2021. Pricing is firm fixed price.</p>

<p>The NIH Clinical Center awarded a purchase order to Polypeptide Laboratories San Diego, LLC for $24,500 on February 15, 2019. Work is performed in San Diego, California. The order is firm fixed price with an ultimate completion date of March 2, 2019. No set-aside category applies to this purchase order.</p>

<p>The National Institutes of Health Clinical Center issued a purchase order to Polypeptide Laboratories Inc. for $24,500.00 on February 15, 2018. Work is performed in Bethesda, Maryland. The order carries a firm fixed price and an ultimate completion date of February 19, 2018. No set-aside applied to this acquisition.</p>

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $132,000 firm fixed price purchase order to JPT Peptide Technologies GMBH. The contract calls for JPT to design, synthesize, purify, analyze, pool, and test overlapping peptides of the rabies envelope glycoprotein and HPV16 capsid L1 protein. These peptides will be used by NCI's Laboratory of Cellular Oncology to evaluate the potential of viral peptide libraries for cancer treatment. Key...

<p>The National Cancer Institute awarded a purchase order to Societal CDMO San Diego, LLC for $25,000 on June 25, 2019. Work is performed in San Diego, California. The order procures preparation of vials for fill-and-finish operations of TARP reagent peptides (TARP 1-20 and 21-40) used in vaccine manufacturing for CCR clinical trials 15C0075 and 15C0076. Performance concludes July 24, 2019. The awardee is a self-certified small disadvantaged business.</p>

<p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. for $3,597.96 on August 29, 2017, for peptide services. Work is performed in San Diego, California. The order is firm fixed price with an ultimate completion date of September 30, 2017.</p>

<p>The National Cancer Institute awarded a purchase order to Peprotech Inc. for $14,625.00 on September 9, 2019, for biological products. Performance is in Rocky Hill, New Jersey, with completion targeted for October 11, 2019. The order is priced on a firm fixed-price basis with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for biologicals valued at $13,401.67 on March 12, 2020, with an ultimate completion date of April 9, 2020. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to JPT Peptide Technologies GMBH for $16,844.00 on March 6, 2019. The order is for peptides under firm fixed-price terms with an ultimate completion date of May 15, 2019. Place of performance is Germany.</p>